25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Chemclin Diagnostics Co. Ltd. A
Buy, Hold or Sell?

Let's analyze Chemclin together

I guess you are interested in Chemclin Diagnostics Co. Ltd. A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Chemclin Diagnostics Co. Ltd. A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Chemclin Diagnostics Co. Ltd. A

I send you an email if I find something interesting about Chemclin Diagnostics Co. Ltd. A.

1. Quick Overview

1.1. Quick analysis of Chemclin (30 sec.)










1.2. What can you expect buying and holding a share of Chemclin? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
10.5%

What is your share worth?

Current worth
¥3.41
Expected worth in 1 year
¥3.52
How sure are you?
78.9%

+ What do you gain per year?

Total Gains per Share
¥0.12
Return On Investment
1.7%

For what price can you sell your share?

Current Price per Share
¥6.98
Expected price per share
¥6.46 - ¥8.2937995978552
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Chemclin (5 min.)




Live pricePrice per Share (EOD)
¥6.98
Intrinsic Value Per Share
¥-1.54 - ¥-1.76
Total Value Per Share
¥1.87 - ¥1.64

2.2. Growth of Chemclin (5 min.)




Is Chemclin growing?

Current yearPrevious yearGrowGrow %
How rich?$188.4m$188.2m$1.4m0.8%

How much money is Chemclin making?

Current yearPrevious yearGrowGrow %
Making money$5m$5.5m-$426.1k-8.4%
Net Profit Margin32.4%34.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Chemclin (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Chemclin?

Welcome investor! Chemclin's management wants to use your money to grow the business. In return you get a share of Chemclin.

First you should know what it really means to hold a share of Chemclin. And how you can make/lose money.

Speculation

The Price per Share of Chemclin is ¥6.98. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Chemclin.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Chemclin, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.41. Based on the TTM, the Book Value Change Per Share is ¥0.03 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Chemclin.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.2%0.010.2%0.010.2%0.010.2%0.010.2%
Usd Book Value Change Per Share-0.01-0.1%0.000.1%0.000.0%0.020.4%0.020.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-0.1%0.000.1%0.000.0%0.030.4%0.030.4%
Usd Price Per Share0.87-1.20-1.43-1.16-1.16-
Price to Earnings Ratio16.59-24.91-26.83-23.62-23.62-
Price-to-Total Gains Ratio-145.08--107.20-69.67-19.03-19.03-
Price to Book Ratio1.86-2.54-3.05-2.57-2.57-
Price-to-Total Gains Ratio-145.08--107.20-69.67-19.03-19.03-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.96324
Number of shares1038
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.02
Usd Total Gains Per Share0.000.03
Gains per Quarter (1038 shares)4.2727.28
Gains per Year (1038 shares)17.08109.13
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10177610399
20342413205208
30514119308317
40685826411426
50857532513535
601029239616644
7012010945719753
8013712652822862
9015414358924971
1001711606410271080

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%19.00.00.0100.0%
Book Value Change Per Share2.02.00.050.0%8.04.00.066.7%13.05.01.068.4%13.05.01.068.4%13.05.01.068.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%2.00.017.010.5%2.00.017.010.5%2.00.017.010.5%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%15.04.00.078.9%15.04.00.078.9%15.04.00.078.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Chemclin Diagnostics Co. Ltd. A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0440.030-246%0.019-329%0.179-124%0.179-124%
Book Value Per Share--3.4053.428-1%3.401+0%2.951+15%2.951+15%
Current Ratio--5.4765.647-3%6.722-19%6.246-12%6.246-12%
Debt To Asset Ratio--0.2440.233+5%0.133+84%0.147+67%0.147+67%
Debt To Equity Ratio--0.3240.304+6%0.155+109%0.176+84%0.176+84%
Dividend Per Share----0%-0%0.011-100%0.011-100%
Eps--0.0950.092+4%0.100-4%0.089+8%0.089+8%
Free Cash Flow Per Share--0.058-0.026+146%-0.123+313%-0.014+125%-0.014+125%
Free Cash Flow To Equity Per Share--0.058-0.026+146%-0.122+312%-0.012+121%-0.012+121%
Gross Profit Margin--1.0001.0000%0.583+71%0.562+78%0.562+78%
Intrinsic Value_10Y_max---1.763--------
Intrinsic Value_10Y_min---1.536--------
Intrinsic Value_1Y_max---0.196--------
Intrinsic Value_1Y_min---0.192--------
Intrinsic Value_3Y_max---0.574--------
Intrinsic Value_3Y_min---0.548--------
Intrinsic Value_5Y_max---0.934--------
Intrinsic Value_5Y_min---0.869--------
Market Cap2799733840.000+9%2539013640.0003499667300.000-27%4164503810.000-39%3365929448.421-25%3365929448.421-25%
Net Profit Margin--0.3350.324+3%0.346-3%0.309+8%0.309+8%
Operating Margin----0%0.287-100%0.114-100%0.114-100%
Operating Ratio--0.8900.909-2%0.723+23%0.647+38%0.647+38%
Pb Ratio2.050+9%1.8592.545-27%3.047-39%2.569-28%2.569-28%
Pe Ratio18.299+9%16.59524.909-33%26.831-38%23.619-30%23.619-30%
Price Per Share6.980+9%6.3308.725-27%10.383-39%8.392-25%8.392-25%
Price To Free Cash Flow Ratio30.320+9%27.496-56.373+305%-21.579+178%-24.689+190%-24.689+190%
Price To Total Gains Ratio-159.976-10%-145.079-107.204-26%69.668-308%19.032-862%19.032-862%
Quick Ratio--2.5612.554+0%8.485-70%7.354-65%7.354-65%
Return On Assets--0.0210.021+3%0.025-17%0.026-20%0.026-20%
Return On Equity--0.0280.027+4%0.029-5%0.031-9%0.031-9%
Total Gains Per Share---0.0440.030-246%0.019-329%0.190-123%0.190-123%
Usd Book Value--188490717.137189740299.477-1%188240326.516+0%163330878.556+15%163330878.556+15%
Usd Book Value Change Per Share---0.0060.004-246%0.003-329%0.025-124%0.025-124%
Usd Book Value Per Share--0.4700.473-1%0.469+0%0.407+15%0.407+15%
Usd Dividend Per Share----0%-0%0.002-100%0.002-100%
Usd Eps--0.0130.013+4%0.014-4%0.012+8%0.012+8%
Usd Free Cash Flow--3185731.151-1460950.553+146%-6784354.160+313%-795327.572+125%-795327.572+125%
Usd Free Cash Flow Per Share--0.008-0.004+146%-0.017+313%-0.002+125%-0.002+125%
Usd Free Cash Flow To Equity Per Share--0.008-0.004+146%-0.017+312%-0.002+121%-0.002+121%
Usd Market Cap386363269.920+9%350383882.320482954087.400-27%574701525.780-39%464498263.882-25%464498263.882-25%
Usd Price Per Share0.963+9%0.8741.204-27%1.433-39%1.158-25%1.158-25%
Usd Profit--5278477.1585084752.794+4%5510918.130-4%4904195.447+8%4904195.447+8%
Usd Revenue--15758960.74515584009.967+1%15903065.101-1%15593252.034+1%15593252.034+1%
Usd Total Gains Per Share---0.0060.004-246%0.003-329%0.026-123%0.026-123%
 EOD+3 -5MRQTTM+17 -15YOY+12 -225Y+17 -1910Y+17 -19

3.3 Fundamental Score

Let's check the fundamental score of Chemclin Diagnostics Co. Ltd. A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1518.299
Price to Book Ratio (EOD)Between0-12.050
Net Profit Margin (MRQ)Greater than00.335
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.561
Current Ratio (MRQ)Greater than15.476
Debt to Asset Ratio (MRQ)Less than10.244
Debt to Equity Ratio (MRQ)Less than10.324
Return on Equity (MRQ)Greater than0.150.028
Return on Assets (MRQ)Greater than0.050.021
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Chemclin Diagnostics Co. Ltd. A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.502
Ma 20Greater thanMa 507.131
Ma 50Greater thanMa 1006.584
Ma 100Greater thanMa 2006.330
OpenGreater thanClose7.260
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Chemclin Diagnostics Co. Ltd. A

Chemclin Diagnostics Co., Ltd. engages in the research and development, production, and sale of clinical immune chemiluminescence diagnostic reagents and instruments. Its products include LiCAA series of diagnostic reagents based on photo-induced chemiluminescence and CC series based on enzymatic chemiluminescence diagnostic reagents and instruments, primarily used for infectious diseases, such as hepatitis B, hepatitis C, AIDS, syphilis, hepatitis A, hepatitis E, etc.; and detection of tumor markers, thyroid hormones, reproductive endocrine hormones, cardiac markers, and inflammation. The company was founded in 2007 and is headquartered in Beijing, China.

Fundamental data was last updated by Penke on 2024-11-10 10:49:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Chemclin earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Chemclin to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 33.5% means that ¥0.33 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Chemclin Diagnostics Co. Ltd. A:

  • The MRQ is 33.5%. The company is making a huge profit. +2
  • The TTM is 32.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ33.5%TTM32.4%+1.1%
TTM32.4%YOY34.6%-2.1%
TTM32.4%5Y30.9%+1.5%
5Y30.9%10Y30.9%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ33.5%-5.6%+39.1%
TTM32.4%-8.8%+41.2%
YOY34.6%-0.8%+35.4%
5Y30.9%-1.9%+32.8%
10Y30.9%-0.3%+31.2%
4.3.1.2. Return on Assets

Shows how efficient Chemclin is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Chemclin to the Diagnostics & Research industry mean.
  • 2.1% Return on Assets means that Chemclin generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Chemclin Diagnostics Co. Ltd. A:

  • The MRQ is 2.1%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.1%TTM2.1%+0.1%
TTM2.1%YOY2.5%-0.5%
TTM2.1%5Y2.6%-0.6%
5Y2.6%10Y2.6%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1%-1.2%+3.3%
TTM2.1%-2.1%+4.2%
YOY2.5%-0.9%+3.4%
5Y2.6%-0.1%+2.7%
10Y2.6%-0.5%+3.1%
4.3.1.3. Return on Equity

Shows how efficient Chemclin is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Chemclin to the Diagnostics & Research industry mean.
  • 2.8% Return on Equity means Chemclin generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Chemclin Diagnostics Co. Ltd. A:

  • The MRQ is 2.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.8%TTM2.7%+0.1%
TTM2.7%YOY2.9%-0.3%
TTM2.7%5Y3.1%-0.4%
5Y3.1%10Y3.1%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8%-0.4%+3.2%
TTM2.7%-1.7%+4.4%
YOY2.9%0.3%+2.6%
5Y3.1%-0.9%+4.0%
10Y3.1%-0.9%+4.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Chemclin Diagnostics Co. Ltd. A.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Chemclin is operating .

  • Measures how much profit Chemclin makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Chemclin to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Chemclin Diagnostics Co. Ltd. A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY28.7%-28.7%
TTM-5Y11.4%-11.4%
5Y11.4%10Y11.4%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--9.6%+9.6%
TTM--12.4%+12.4%
YOY28.7%2.6%+26.1%
5Y11.4%1.4%+10.0%
10Y11.4%4.1%+7.3%
4.3.2.2. Operating Ratio

Measures how efficient Chemclin is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.89 means that the operating costs are ¥0.89 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Chemclin Diagnostics Co. Ltd. A:

  • The MRQ is 0.890. The company is less efficient in keeping operating costs low.
  • The TTM is 0.909. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.890TTM0.909-0.019
TTM0.909YOY0.723+0.186
TTM0.9095Y0.647+0.262
5Y0.64710Y0.6470.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8901.311-0.421
TTM0.9091.294-0.385
YOY0.7231.266-0.543
5Y0.6471.208-0.561
10Y0.6471.191-0.544
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Chemclin Diagnostics Co. Ltd. A.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Chemclin is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 5.48 means the company has ¥5.48 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Chemclin Diagnostics Co. Ltd. A:

  • The MRQ is 5.476. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.647. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.476TTM5.647-0.171
TTM5.647YOY6.722-1.075
TTM5.6475Y6.246-0.599
5Y6.24610Y6.2460.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4762.028+3.448
TTM5.6472.113+3.534
YOY6.7222.555+4.167
5Y6.2462.668+3.578
10Y6.2463.230+3.016
4.4.3.2. Quick Ratio

Measures if Chemclin is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Chemclin to the Diagnostics & Research industry mean.
  • A Quick Ratio of 2.56 means the company can pay off ¥2.56 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Chemclin Diagnostics Co. Ltd. A:

  • The MRQ is 2.561. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.554. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.561TTM2.554+0.007
TTM2.554YOY8.485-5.930
TTM2.5545Y7.354-4.800
5Y7.35410Y7.3540.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5611.206+1.355
TTM2.5541.241+1.313
YOY8.4851.685+6.800
5Y7.3542.100+5.254
10Y7.3542.428+4.926
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Chemclin Diagnostics Co. Ltd. A.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Chemclin assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Chemclin to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.24 means that Chemclin assets are financed with 24.4% credit (debt) and the remaining percentage (100% - 24.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Chemclin Diagnostics Co. Ltd. A:

  • The MRQ is 0.244. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.233. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.244TTM0.233+0.011
TTM0.233YOY0.133+0.100
TTM0.2335Y0.147+0.086
5Y0.14710Y0.1470.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2440.437-0.193
TTM0.2330.440-0.207
YOY0.1330.359-0.226
5Y0.1470.428-0.281
10Y0.1470.450-0.303
4.5.4.2. Debt to Equity Ratio

Measures if Chemclin is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Chemclin to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 32.4% means that company has ¥0.32 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Chemclin Diagnostics Co. Ltd. A:

  • The MRQ is 0.324. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.304. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.324TTM0.304+0.019
TTM0.304YOY0.155+0.149
TTM0.3045Y0.176+0.128
5Y0.17610Y0.1760.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3240.640-0.316
TTM0.3040.686-0.382
YOY0.1550.502-0.347
5Y0.1760.666-0.490
10Y0.1760.712-0.536
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Chemclin generates.

  • Above 15 is considered overpriced but always compare Chemclin to the Diagnostics & Research industry mean.
  • A PE ratio of 16.59 means the investor is paying ¥16.59 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Chemclin Diagnostics Co. Ltd. A:

  • The EOD is 18.299. Based on the earnings, the company is fair priced.
  • The MRQ is 16.595. Based on the earnings, the company is fair priced.
  • The TTM is 24.909. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD18.299MRQ16.595+1.704
MRQ16.595TTM24.909-8.314
TTM24.909YOY26.831-1.922
TTM24.9095Y23.619+1.290
5Y23.61910Y23.6190.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD18.299-0.356+18.655
MRQ16.595-0.693+17.288
TTM24.909-0.881+25.790
YOY26.831-0.145+26.976
5Y23.6191.937+21.682
10Y23.6193.727+19.892
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Chemclin Diagnostics Co. Ltd. A:

  • The EOD is 30.320. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 27.496. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -56.373. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD30.320MRQ27.496+2.823
MRQ27.496TTM-56.373+83.870
TTM-56.373YOY-21.579-34.794
TTM-56.3735Y-24.689-31.685
5Y-24.68910Y-24.6890.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD30.320-0.676+30.996
MRQ27.496-1.088+28.584
TTM-56.373-1.123-55.250
YOY-21.579-2.356-19.223
5Y-24.689-2.367-22.322
10Y-24.689-2.248-22.441
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Chemclin is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.86 means the investor is paying ¥1.86 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Chemclin Diagnostics Co. Ltd. A:

  • The EOD is 2.050. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.859. Based on the equity, the company is underpriced. +1
  • The TTM is 2.545. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.050MRQ1.859+0.191
MRQ1.859TTM2.545-0.686
TTM2.545YOY3.047-0.502
TTM2.5455Y2.569-0.024
5Y2.56910Y2.5690.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.0502.279-0.229
MRQ1.8592.309-0.450
TTM2.5452.317+0.228
YOY3.0472.384+0.663
5Y2.5693.753-1.184
10Y2.5694.539-1.970
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,807,763
Total Liabilities441,889
Total Stockholder Equity1,365,875
 As reported
Total Liabilities 441,889
Total Stockholder Equity+ 1,365,875
Total Assets = 1,807,763

Assets

Total Assets1,807,763
Total Current Assets1,020,985
Long-term Assets786,778
Total Current Assets
Cash And Cash Equivalents 394,779
Short-term Investments 453,000
Net Receivables 24,546
Inventory 111,019
Other Current Assets 25,689
Total Current Assets  (as reported)1,020,985
Total Current Assets  (calculated)1,009,032
+/- 11,953
Long-term Assets
Property Plant Equipment 523,096
Goodwill 153,756
Intangible Assets 52,768
Long-term Assets  (as reported)786,778
Long-term Assets  (calculated)729,620
+/- 57,159

Liabilities & Shareholders' Equity

Total Current Liabilities186,433
Long-term Liabilities255,455
Total Stockholder Equity1,365,875
Total Current Liabilities
Short Long Term Debt 5,968
Accounts payable 88,678
Other Current Liabilities 739
Total Current Liabilities  (as reported)186,433
Total Current Liabilities  (calculated)95,385
+/- 91,048
Long-term Liabilities
Long term Debt 220,383
Capital Lease Obligations Min Short Term Debt26,178
Long-term Liabilities  (as reported)255,455
Long-term Liabilities  (calculated)246,561
+/- 8,895
Total Stockholder Equity
Retained Earnings 396,307
Total Stockholder Equity (as reported)1,365,875
Total Stockholder Equity (calculated)396,307
+/- 969,568
Other
Capital Stock401,108
Common Stock Shares Outstanding 401,108
Net Invested Capital 1,592,226
Net Working Capital 834,552
Property Plant and Equipment Gross 523,096



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
0
993,392
0
928,689
962,761
1,006,823
1,080,465
1,354,822
1,400,483
1,430,907
1,470,695
1,462,767
1,518,754
1,591,166
1,577,017
1,610,672
1,725,319
1,820,563
1,819,305
1,807,763
1,807,7631,819,3051,820,5631,725,3191,610,6721,577,0171,591,1661,518,7541,462,7671,470,6951,430,9071,400,4831,354,8221,080,4651,006,823962,761928,6890993,3920
   > Total Current Assets 
0
709,499
0
633,653
0
702,340
745,372
1,018,165
1,063,017
1,091,293
1,133,484
1,113,376
1,162,043
1,165,252
1,137,752
1,040,763
1,094,791
1,102,627
1,048,955
1,020,985
1,020,9851,048,9551,102,6271,094,7911,040,7631,137,7521,165,2521,162,0431,113,3761,133,4841,091,2931,063,0171,018,165745,372702,3400633,6530709,4990
       Cash And Cash Equivalents 
0
103,157
0
94,426
0
224,817
271,878
406,921
176,210
311,631
338,869
368,675
349,575
342,140
247,051
354,989
353,389
448,663
505,251
394,779
394,779505,251448,663353,389354,989247,051342,140349,575368,675338,869311,631176,210406,921271,878224,817094,4260103,1570
       Short-term Investments 
0
480,000
0
407,000
0
328,573
303,000
448,000
721,000
613,000
633,000
577,000
639,000
643,000
705,000
491,700
535,000
470,000
373,000
453,000
453,000373,000470,000535,000491,700705,000643,000639,000577,000633,000613,000721,000448,000303,000328,5730407,0000480,0000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
33,075
31,468
32,175
34,063
31,493
28,374
29,691
25,287
22,030
24,546
24,54622,03025,28729,69128,37431,49334,06332,17531,46833,0750000000000
       Other Current Assets 
0
42,250
0
38,939
0
50,277
63,181
46,037
44,220
44,299
762
2,062
353
4,515
979
13,123
18,406
21,722
24,160
25,689
25,68924,16021,72218,40613,1239794,5153532,06276244,29944,22046,03763,18150,277038,939042,2500
   > Long-term Assets 
0
283,893
0
295,036
962,761
304,483
335,093
336,657
337,466
339,614
337,211
349,391
356,711
425,914
439,265
569,909
630,529
717,935
770,350
786,778
786,778770,350717,935630,529569,909439,265425,914356,711349,391337,211339,614337,466336,657335,093304,483962,761295,0360283,8930
       Property Plant Equipment 
0
119,150
0
116,980
0
125,536
156,165
157,409
157,066
157,851
154,417
157,585
159,087
223,438
230,874
356,107
410,932
495,013
539,132
523,096
523,096539,132495,013410,932356,107230,874223,438159,087157,585154,417157,851157,066157,409156,165125,5360116,9800119,1500
       Goodwill 
0
153,756
0
153,756
0
153,756
153,756
153,756
153,756
153,756
153,756
153,756
153,756
153,756
153,756
153,756
153,756
153,756
153,756
153,756
153,756153,756153,756153,756153,756153,756153,756153,756153,756153,756153,756153,756153,756153,756153,7560153,7560153,7560
       Intangible Assets 
0
584
0
14,345
0
14,067
14,092
14,042
13,897
13,753
13,829
18,168
23,265
28,696
33,022
37,619
43,492
45,341
45,582
52,768
52,76845,58245,34143,49237,61933,02228,69623,26518,16813,82913,75313,89714,04214,09214,067014,34505840
> Total Liabilities 
0
126,417
0
127,564
116,207
119,464
154,968
148,891
156,764
152,234
149,390
175,254
176,559
210,591
161,605
292,612
363,653
431,761
435,929
441,889
441,889435,929431,761363,653292,612161,605210,591176,559175,254149,390152,234156,764148,891154,968119,464116,207127,5640126,4170
   > Total Current Liabilities 
0
115,091
0
114,913
0
104,730
110,126
105,133
122,951
121,557
121,254
150,608
155,339
197,255
138,610
196,631
190,724
194,135
184,269
186,433
186,433184,269194,135190,724196,631138,610197,255155,339150,608121,254121,557122,951105,133110,126104,7300114,9130115,0910
       Short-term Debt 
0
0
0
0
0
0
0
0
10,901
11,388
11,495
11,276
8,974
10,898
8,048
0
0
0
0
0
000008,04810,8988,97411,27611,49511,38810,90100000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
11,495
11,276
8,974
10,898
8,048
3,851
1,609
6,659
5,446
5,968
5,9685,4466,6591,6093,8518,04810,8988,97411,27611,4950000000000
       Accounts payable 
0
23,123
0
22,351
0
32,042
29,414
32,909
28,808
22,027
22,537
34,731
28,230
67,753
36,731
104,833
91,761
90,237
86,935
88,678
88,67886,93590,23791,761104,83336,73167,75328,23034,73122,53722,02728,80832,90929,41432,042022,351023,1230
       Other Current Liabilities 
0
85,741
0
86,831
0
62,554
69,545
64,139
72,127
88,142
87,222
104,602
118,135
118,603
93,830
603
781
899
903
739
73990389978160393,830118,603118,135104,60287,22288,14272,12764,13969,54562,554086,831085,7410
   > Long-term Liabilities 
0
11,327
0
12,651
116,207
14,734
44,841
43,757
33,813
30,677
28,137
24,646
21,221
13,336
22,995
95,981
172,929
237,626
251,660
255,455
255,455251,660237,626172,92995,98122,99513,33621,22124,64628,13730,67733,81343,75744,84114,734116,20712,651011,3270
> Total Stockholder Equity
0
866,975
0
801,125
846,554
887,359
925,498
1,205,931
1,243,719
1,278,673
1,321,305
1,287,513
1,342,194
1,380,575
1,415,412
1,318,060
1,361,667
1,388,802
1,383,376
1,365,875
1,365,8751,383,3761,388,8021,361,6671,318,0601,415,4121,380,5751,342,1941,287,5131,321,3051,278,6731,243,7191,205,931925,498887,359846,554801,1250866,9750
   Common Stock
0
360,000
0
360,000
0
360,000
360,000
401,000
401,000
401,000
401,000
401,000
401,000
401,000
401,000
0
0
0
0
0
00000401,000401,000401,000401,000401,000401,000401,000401,000360,000360,0000360,0000360,0000
   Retained Earnings Total Equity00000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
354,335
0
357,319
846,554
357,699
357,699
565,256
565,256
572,217
575,741
579,706
585,657
605,146
605,146
0
0
0
0
0
00000605,146605,146585,657579,706575,741572,217565,256565,256357,699357,699846,554357,3190354,3350



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue445,341
Cost of Revenue-109,723
Gross Profit335,617335,617
 
Operating Income (+$)
Gross Profit335,617
Operating Expense-297,518
Operating Income147,82338,100
 
Operating Expense (+$)
Research Development65,768
Selling General Administrative107,098
Selling And Marketing Expenses0
Operating Expense297,518172,865
 
Net Interest Income (+$)
Interest Income7,270
Interest Expense-472
Other Finance Cost-147
Net Interest Income6,651
 
Pretax Income (+$)
Operating Income147,823
Net Interest Income6,651
Other Non-Operating Income Expenses0
Income Before Tax (EBT)166,120147,823
EBIT - interestExpense = -472
147,374
147,846
Interest Expense472
Earnings Before Interest and Taxes (EBIT)0166,592
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax166,120
Tax Provision-18,746
Net Income From Continuing Ops147,374147,374
Net Income147,374
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-6,651
 

Technical Analysis of Chemclin
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Chemclin. The general trend of Chemclin is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Chemclin's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Chemclin Diagnostics Co. Ltd. A.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7.89 < 8.2 < 8.2937995978552.

The bearish price targets are: 6.6 > 6.6 > 6.46.

Tweet this
Chemclin Diagnostics Co. Ltd. A Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Chemclin Diagnostics Co. Ltd. A. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Chemclin Diagnostics Co. Ltd. A Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Chemclin Diagnostics Co. Ltd. A. The current macd is 0.14430975.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Chemclin price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Chemclin. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Chemclin price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Chemclin Diagnostics Co. Ltd. A Daily Moving Average Convergence/Divergence (MACD) ChartChemclin Diagnostics Co. Ltd. A Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Chemclin Diagnostics Co. Ltd. A. The current adx is 31.77.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Chemclin shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Chemclin Diagnostics Co. Ltd. A Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Chemclin Diagnostics Co. Ltd. A. The current sar is 7.89.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Chemclin Diagnostics Co. Ltd. A Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Chemclin Diagnostics Co. Ltd. A. The current rsi is 49.50. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Chemclin Diagnostics Co. Ltd. A Daily Relative Strength Index (RSI) ChartChemclin Diagnostics Co. Ltd. A Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Chemclin Diagnostics Co. Ltd. A. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Chemclin price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Chemclin Diagnostics Co. Ltd. A Daily Stochastic Oscillator ChartChemclin Diagnostics Co. Ltd. A Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Chemclin Diagnostics Co. Ltd. A. The current cci is -19.30843707.

Chemclin Diagnostics Co. Ltd. A Daily Commodity Channel Index (CCI) ChartChemclin Diagnostics Co. Ltd. A Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Chemclin Diagnostics Co. Ltd. A. The current cmo is -10.14132979.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Chemclin Diagnostics Co. Ltd. A Daily Chande Momentum Oscillator (CMO) ChartChemclin Diagnostics Co. Ltd. A Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Chemclin Diagnostics Co. Ltd. A. The current willr is -78.44827586.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Chemclin is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Chemclin Diagnostics Co. Ltd. A Daily Williams %R ChartChemclin Diagnostics Co. Ltd. A Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Chemclin Diagnostics Co. Ltd. A.

Chemclin Diagnostics Co. Ltd. A Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Chemclin Diagnostics Co. Ltd. A. The current atr is 0.27593414.

Chemclin Diagnostics Co. Ltd. A Daily Average True Range (ATR) ChartChemclin Diagnostics Co. Ltd. A Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Chemclin Diagnostics Co. Ltd. A. The current obv is 53,760,373.

Chemclin Diagnostics Co. Ltd. A Daily On-Balance Volume (OBV) ChartChemclin Diagnostics Co. Ltd. A Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Chemclin Diagnostics Co. Ltd. A. The current mfi is 66.18.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Chemclin Diagnostics Co. Ltd. A Daily Money Flow Index (MFI) ChartChemclin Diagnostics Co. Ltd. A Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Chemclin Diagnostics Co. Ltd. A.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Chemclin Diagnostics Co. Ltd. A Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Chemclin Diagnostics Co. Ltd. A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.502
Ma 20Greater thanMa 507.131
Ma 50Greater thanMa 1006.584
Ma 100Greater thanMa 2006.330
OpenGreater thanClose7.260
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Chemclin with someone you think should read this too:
  • Are you bullish or bearish on Chemclin? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Chemclin? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Chemclin Diagnostics Co. Ltd. A

I send you an email if I find something interesting about Chemclin Diagnostics Co. Ltd. A.


Comments

How you think about this?

Leave a comment

Stay informed about Chemclin Diagnostics Co. Ltd. A.

Receive notifications about Chemclin Diagnostics Co. Ltd. A in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.